Wordt geladen...
CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial
BACKGROUND: The inflammatory response after aneurysmal subarachnoid haemorrhage (aSAH) has been associated with early brain injury, delayed cerebral ischaemia, poor functional outcome, and case fatality. In experimental SAH studies, complement C5 antibodies administered shortly after SAH reduced bra...
Bewaard in:
| Gepubliceerd in: | Trials |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7687754/ https://ncbi.nlm.nih.gov/pubmed/33239044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04838-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|